Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $45,047 | 28 | 70.8% |
| Travel and Lodging | $10,823 | 9 | 17.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,880 | 5 | 9.2% |
| Unspecified | $1,400 | 1 | 2.2% |
| Food and Beverage | $465.61 | 14 | 0.7% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $16,515 | 5 | $0 (2020) |
| Janssen Research & Development, LLC | $14,852 | 18 | $0 (2020) |
| AstraZeneca UK Limited | $10,723 | 16 | $0 (2018) |
| AstraZeneca AB | $9,233 | 8 | $0 (2020) |
| PFIZER INC. | $8,655 | 7 | $0 (2021) |
| Chiesi USA, Inc. | $2,763 | 2 | $0 (2018) |
| Medtronic, Inc. | $875.00 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $2,250 | 2 | PFIZER INC. ($1,375) |
| 2020 | $20,790 | 10 | Medtronic Vascular, Inc. ($16,515) |
| 2019 | $11,592 | 15 | Janssen Research & Development, LLC ($7,187) |
| 2018 | $12,700 | 16 | PFIZER INC. ($4,760) |
| 2017 | $16,284 | 14 | AstraZeneca UK Limited ($9,846) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/12/2021 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $875.00 | General |
| 05/03/2021 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $1,375.00 | General |
| 12/14/2020 | AstraZeneca AB | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 08/05/2020 | Medtronic Vascular, Inc. | HeartWare HVAD (Device) | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| Category: Ventricular Assist Devices | ||||||
| 08/03/2020 | Janssen Research & Development, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/20/2020 | Medtronic Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $8,165.00 | General |
| 07/20/2020 | Medtronic Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,015.00 | General |
| 07/20/2020 | Medtronic Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 07/16/2020 | Medtronic Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,585.00 | General |
| 06/19/2020 | Janssen Research & Development, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/27/2020 | PFIZER INC. | — | — | In-kind items and services | $1,400.00 | Research |
| Study: RIVIPANSEL CLINICAL PUBLICATION PROGRAM | ||||||
| 01/27/2020 | Janssen Research & Development, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $875.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/17/2019 | AstraZeneca AB | BRILINTA (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/16/2019 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $780.00 | General |
| 12/11/2019 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $4,501.26 | General |
| 12/11/2019 | Janssen Research & Development, LLC | — | Travel and Lodging | Cash or cash equivalent | $335.41 | General |
| 12/11/2019 | Janssen Research & Development, LLC | — | Food and Beverage | Cash or cash equivalent | $24.30 | General |
| 12/10/2019 | AstraZeneca AB | BRILINTA (Drug) | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/27/2019 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $52.60 | General |
| 11/27/2019 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $30.60 | General |
| 11/27/2019 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $30.60 | General |
| 11/27/2019 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $19.13 | General |
| 11/11/2019 | Janssen Research & Development, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $415.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/18/2019 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $73.30 | General |
| 06/27/2019 | AstraZeneca AB | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RIVIPANSEL CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $1,400 | 1 |
About Dr. Alan Michelson, M.D
Dr. Alan Michelson, M.D is a Pediatric Hematology-Oncology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760464994.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Michelson, M.D has received a total of $63,616 in payments from pharmaceutical and medical device companies, with $2,250 received in 2021. These payments were reported across 57 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($45,047).
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Boston, MA
- Active Since 11/15/2005
- Last Updated 05/22/2009
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1760464994
Products in Payments
- BRILINTA (Drug) $13,398
- XARELTO (Drug) $9,785
- KENGREAL (Drug) $2,763
- HeartWare HVAD (Device) $1,250
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Boston
Mr. Alan Dandrea, Md, MD
Pediatric Hematology-Oncology — Payments: $826,972
Dr. Leslie Kean, Md/Phd, MD/PHD
Pediatric Hematology-Oncology — Payments: $326,453
Todd Golub, M.d, M.D
Pediatric Hematology-Oncology — Payments: $247,953
Dr. Stacy Croteau, Md, MD
Pediatric Hematology-Oncology — Payments: $219,942
Matthew Heeney, Md, MD
Pediatric Hematology-Oncology — Payments: $201,707
Christine Duncan, M.d, M.D
Pediatric Hematology-Oncology — Payments: $74,023